# Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions

> **NCT00371423** · PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 247 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** TAXUS Liberté™-SR
- **DEVICE:** TAXUS Liberté™-SR

## Key facts

- **NCT ID:** NCT00371423
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2006-06
- **Final completion:** 2010-09
- **Target enrollment:** 247 (ACTUAL)
- **Last updated:** 2012-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00371423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00371423, "Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00371423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*